Filing Flows › Madrigal Pharmaceuticals (MDGL) › How it makes money
How Madrigal Pharmaceuticals (MDGL) makes money
Madrigal Pharmaceuticals (MDGL) made $431M of revenue in the third quarter 2026 (Q3 2026), +50% from a year earlier. Of every dollar of revenue, 13¢ was left as operating profit, 13¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $431M | 100.0% |
| Operating profit | $56.0M | 13.0% |
| Net earnings | $55.4M | 12.9% |
| Operating cash flow | $121M | 28.0% |
| Free cash flow | $117M | 27.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $431M | +50% |
| Q2 2026 | $364M | +71% |
| Q1 2026 | $311M | +127% |
| Q4 2025 | $321M | +211% |
| Q3 2025 | $287M | +362% |
| Q2 2025 | $213M | 15× |
| Q1 2025 | $137M | — |
From Madrigal Pharmaceuticals' 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does Madrigal Pharmaceuticals make money?
Madrigal Pharmaceuticals (MDGL) made $431M of revenue in the third quarter 2026 (Q3 2026), +50% from a year earlier. Of every dollar of revenue, 13¢ was left as operating profit, 13¢ was left as net earnings.
What is Madrigal Pharmaceuticals' profit margin?
Net earnings were $55.4M, 12.9% of revenue, in the third quarter 2026; the operating margin was 13.0%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.